These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)]. Spasova K, Vŭlcheva B. Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168 [No Abstract] [Full Text] [Related]
8. [Prevention of maternal isoimmunization to RhD antigen]. Baptista González HA, Rosenfeld Mann F. Salud Publica Mex; 2004; 46(3):194-5; author reply 196-7. PubMed ID: 15368858 [No Abstract] [Full Text] [Related]
10. The use of Rh immune globulin: a review. Sutton GP, Jay A, Lim YS, Noland JE, Boral LI. Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434 [No Abstract] [Full Text] [Related]
11. Preventing RhD haemolytic disease of the newborn. van Dijk B. BMJ; 1997 Dec 06; 315(7121):1480-1. PubMed ID: 9420481 [No Abstract] [Full Text] [Related]
13. [Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum]. Larsen JF, Bock JE, Jørgensen JR. Ugeskr Laeger; 2004 Aug 30; 166(36):3078-83. PubMed ID: 15387304 [No Abstract] [Full Text] [Related]
14. [Recommendations for clinical practice. Prevention in maternofetal Rh immunization (December 2005)]. Collège National des Gynécologues et Obstétriciens Français. Gynecol Obstet Fertil; 2006 Apr 30; 34(4):360-5. PubMed ID: 16644259 [No Abstract] [Full Text] [Related]
20. Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP. Med Lett Drugs Ther; 1996 Jan 19; 38(966):6-8. PubMed ID: 8544794 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]